Latest Regulatory Compliance News

Atomo Diagnostics has responded to ASX queries confirming it first held market-sensitive information after Lumos Diagnostics’ FDA CLIA waiver approval for FebriDx. The company defended its trading halt and capital raise timing, asserting full compliance with ASX Listing Rules.

Emu NL's EMUOA securities have been suspended from trading by the ASX, pending compliance with listing rules. This move affects only the EMUOA class and signals regulatory scrutiny ahead of the company's next steps.

Hartshead Resources has secured regulatory consent from the North Sea Transition Authority for its acquisition by ACAM GP Limited and updated the indicative timetable for the scheme of arrangement, pushing key shareholder and court dates into mid-2026.

Macarthur Minerals (ASX:MIO) has clarified the timing of its cleansing notice relative to a key Programme of Work approval, affirming compliance with ASX continuous disclosure rules and explaining the rationale behind delayed disclosure.

Accordant Group Limited’s shareholders have approved a significant share issuance under a Rights Offer, allowing the Hull Family Trust to increase its voting control beyond 20%. The move also greenlights additional share allocations to related parties to cover subscription shortfalls.

Netwealth delivered a resilient March quarter with $4 billion in net inflows, pushing total funds under administration to $125.8 billion despite a 3.7% market dip. Growth in Managed Accounts and new intermediary relationships underpin ongoing momentum.

Trek Metals has wrapped up the second tranche of its $15 million placement, issuing nearly 9.7 million shares to directors at 15 cents each after shareholder approval. The move bolsters the company’s capital ahead of its drilling campaign at the Kuro manganese prospect.

WhiteHawk Limited has raised A$1.5 million through a share placement to fund integration and growth of its newly acquired Quixxi Clarity AI platform, marking a strategic push into the AI governance market.

Xenitra Limited has acquired Hong Kong Fukang Trading Co., including key pharmaceutical licenses and ecommerce assets, to fully operationalise its OTC medicine business in Hong Kong and China.

Rhythm Biosciences has clarified inconsistencies in its disclosures around termination events in its underwriting agreement for RHYO options, following an ASX query. The company acknowledged an incomplete initial summary and administrative oversights but confirmed the agreement remains in full effect.

Tarrina Resources (ASX: TR8) has addressed ASX’s query on recent share price movement, confirming it has dispatched soil and drill core samples for laboratory testing with results expected by late April. The company maintains strict confidentiality protocols and affirms compliance with continuous disclosure rules.

Blackstone Minerals has cleared a major regulatory hurdle with the lifting of a Cease and Desist Order at its Mankayan Copper-Gold Project, setting the stage for a pivotal Pre-Feasibility Study drilling campaign.